Background-Hypersecretion of insulinotropic factors such as glucose dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36)amide (GLP-1) have been postulated to account for the hyperinsulinaemia of obesity. Aims-To examine the role of GLP-1 and GIP in obese women and matched controls. Subjects-Six lean and six obese women subjects matched for age. Methods-The gut hormone, plasma glucose, and serum triglyceride responses were studied over 180 minutes after oral carbohydrate and fat meals. Heparin (10 000 units) was given intravenously at 120 minutes.
L R Ranganath, J M Beety, L M Morgan, J W Wright, R Howland, V Marks Abstract Background-Hypersecretion of insulinotropic factors such as glucose dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36)amide (GLP-1) have been postulated to account for the hyperinsulinaemia of obesity. Aims-To examine the role of GLP-1 and GIP in obese women and matched controls. Subjects-Six lean and six obese women subjects matched for age. Methods-The gut hormone, plasma glucose, and serum triglyceride responses were studied over 180 minutes after oral carbohydrate and fat meals. Heparin (10 000 units) was given intravenously at 120 minutes.
Results-There was pronounced attenuation of plasma GLP-1 secretion to oral carbohydrate in the obese compared with lean subjects but no such difference in response to oral fat load. There were no differences in the plasma GIP responses to carbohydrate or fat feeding. There was an apparent fall in plasma GLP-1 values in all subjects after administration of heparin. Conclusion-Postprandial GLP-1 secretion in response to oral carbohydrate is considerably attenuated in obese subjects.
The cause of this attenuation of GLP-1 secretion is not known although we suggest that both this fall and the overall reduction in GLP-1 values in obese subjects may be related to an increase in plasma non-esterified fatty acids. (Gut 1996; 38: 916-919) Keywords: GLP-1, obesity, carbohydrate meal, fat meal. strongly stimulates insulin secretion after carbohydrate, fat, and mixed meals. Molecular biology techniques have shown that posttranslational processing of proglucagon in the pancreas and ileum yields several novel glucagon-like peptides.67 Among these, the truncated fragment of GLP-1 (hitherto called GLP-1 in this paper), has been shown to be strongly insulinotropic and its secretion has been shown to increase after oral glucose and mixed meals.8 9 In addition to its insulinotropic effect, GLP-1 inhibits pancreatic glucagon secretion, decreases hepatic gluconeogenesis, and decreases insulin resistance. 10 11 It has been postulated that an exaggerated 'incretin' factor may have a pathophysiological role in obesity. A role for GIP has been examined in this regard but has not been conclusively shown.5 In this context, it has been suggested that hypersecretion of GLP-1 may be the long sought 'incretin' factor in obesity. 12 Indeed, Fukase and colleagues have examined this hypothesis in a study where they showed increased secretion of glucagon-like peptide-1 in obese diabetic subjects but the responses in non-diabetic obese and matched controls were very similar.
However, the methodology adopted by Fukase and workers for GLP-1 assay was indirect and less specific than that used in this study and included GLP-1(7-37), which is normally present at very low concentrations in plasma, and the two biologically inactive major proglucagon derived fragments. GLP-1 (7-36)amide, measured in this study, is the predominant circulating molecular species of glucagon-like peptides in humans. We undertook this study to (Fig 1) . Figure 2 shows the plas to the test meals. ose, triglyceride, and test meals. The peak tions after oral carboy higher in the obese rea under the curve under the curve (SD) min) (0-180 min) in with lean subjects i) (p<001)). Fasting re higher in obese lter the oral fat load, nder the curve was s (IAUC (SD) of 65 in in lean and obese 0.3 (04) pM/min for lean and obese respectively). There was a decline in plasma concentration of GLP-1 at 150 minutes, 30 minutes after administration of heparin, in both lean and obese subjects when compared with those at 120 minutes (p<0.01).
Plasma GIP concentrations were similar in lean and obese after carbohydrate and fat meals (IAUC (SD) for carbohydrate meals was 41 (5) and 39 (5.3) pM/min respectively in lean and obese; IAUC (SD) for fat meals was 46 (7A4) and 44 (4.2) pM/min respectively in lean and obese) (Fig 3) . s no change in the Discussion s after the oral carbo-This study confirms the finding that, after in serum triglyceride ingestion of both carbohydrate and fat, there is e administration of a prompt rise in the plasma concentrations of groups (Fig 1) . The GLP-1. 17 The greatest rise in GLP-1 concenisulin concentrations trations was seen after carbohydrate in lean ) carbohydrate meal subjects; in the obese, this rise was considersubjects (IAUC (SD) ably attenuated. There was, however, no such 17) pM/min for lean difference between lean and obese subjects ,p<0 05 and p<001 after a fat stimulus.
After carbohydrate, the obese subjects also ;ma GLP-1 responses showed less efficient glucose disposal and mean fasting plasma higher plasma insulin concentrations. The GIP before administration response to carbohydrate feeding was similar lower in obese sub-in the two groups, while the GLP-1 response uch difference in the was lower in the obese. This study does not, rations were noted therefore, lend support to the suggestion that oral fat. Time (min) Figure 3 : Plasma GIP responses to oral carbohydrate andfat in lean and obese subjects.
The mean (SEM) (n= 6) ofplasma GIP in lean ( ) and obese ( 0) subjects are shown.
in GLP-1 after heparin in all subjects after both meals. We considered the possibility that decline after heparin may result from a direct effect of heparin on GLP-1 secretion or to increasing plasma concentrations of nonessential fatty acid released by heparin administration (with parallel decrease in serum triglycerides). As the fall of GLP-1 after heparin was unanticipated, GLP-1 concentrations after glucose load without heparin administration were not measured and the postulated effect of non-esterified fatty acids on GLP-1 remains speculative. We suggest that, although not measured in this study, raised plasma non-esterified fatty acid concentrations, which are known to be associated with obesity18 19 may be the cause for the blunted GLP-1 response to carbohydrate and for the further decline in plasma GLP-1 that follows heparin administration.
